
Sign up to save your podcasts
Or


Mark Odendahl, Head of US Equity Research, and Brian Abrahams, Head of Biotechnology at RBC Capital Markets have a discussion on how website traffic uncovers insights into the sales of leading biopharmaceutical drugs.
By RBC Capital Markets5
1010 ratings
Mark Odendahl, Head of US Equity Research, and Brian Abrahams, Head of Biotechnology at RBC Capital Markets have a discussion on how website traffic uncovers insights into the sales of leading biopharmaceutical drugs.

40 Listeners

12 Listeners

1 Listeners

19 Listeners

3 Listeners